The Disposable Endoscope Market Size was valued at USD 1.9 Billion in 2022 and is projected to grow from USD 2.2 Billion in 2023 to USD 8.6 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.20% during the forecast period (2023 - 2032). Increasing patient desire for minimally invasive procedures and growing need for single-use endoscopes to reduce the risk of device-related infection, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The global market is being driven by the growing use of minimally invasive procedures due to its numerous advantages, including high patient acceptance rates, less pain, cost effectiveness, and a lower risk of consequences. For instance, ambulatory minimally invasive operations are on the rise in the United States, according to NIH data from January 2023. In addition, the need for single-use endoscopic equipment for ENT, bronchoscopy, and dental procedures is expected to expand in the future years across hospitals, diagnostic centres, and other settings.
Additionally, the prevalence of gastrointestinal illnesses such functional dyspepsia and IBS is predicted to rise, along with the use of endoscopic treatments to identify GI problems. For instance, a global study published in the Gastroenterology journal in 2021 found that more than 40% of people globally suffer from functional gastrointestinal diseases. As a result, the prevalence of GI disorders is driving manufacturers to release innovative endoscopic equipment on the market. For instance, Ambu reported in February 2022 that Ambu aScope Gastro and Ambu aBox 2 had received U.S. FDA certification. The company's position in the GI market was bolstered by this clearance.
The market for disposable endoscopes is expected to continue growing as a result of increased hospital investments in endoscopy facilities, increasing endoscopic demand due to the prevalence of target diseases, and endoscopy technology advances. The minimal cost of maintenance, cleaning, and storage of the single-use endoscopes, among other benefits offered by this type of endoscopes, are increasing consumer demand for the product. Additionally, the growing concern of regulatory agencies for patient safety has aided in improving the quality of disposable endoscopes, reducing the number of infections. This situation has been beneficial for the expansion of the sector. Additionally, it is projected that rising target disease prevalence will fuel product demand.
One of the most important factors contributing to the market's expansion is the rise in hospital-acquired infections (HAI) caused by the use of infected endoscopes. Increased regulatory authority sanctions are another factor that will encourage the selling of disposable endoscopes. For instance, the FDA recently approved new disposable endoscopes that provide sterile endoscopic treatment and were produced by the Invendo medical company, which Ambu bought. In contrast, higher disposable endoscope pricing in the coming years will somewhat restrain the market's expansion. Additionally, market participants are spending money on the creation of cheaper, safer medical instruments including disposable gastroscopes, disposable bronchoscopes, and disposable arthroscopes. Additionally, numerous product launches and approvals are accelerating market adoption. For instance, Integrated Endoscopy introduced a second-generation NUVIS disposable arthroscope in November 2022. The recently released arthroscope is the first 4K endoscope of its kind created for use in arthroscopic surgical operations. Thus, driving the Disposable Endoscope market revenue.
The Market segments of Disposable Endoscope, based on Application, includes bronchoscopy, urologic endoscopy, ENT endoscopy, arthroscopy, and others. In 2022, the bronchoscopy segment held the greatest market share. This is explained by the rising incidence of respiratory and lung diseases and the widespread use of minimally invasive bronchoscopy techniques. Over 90% of COPD deaths take place in low- and middle-income countries, and according to the WHO, COPD is the third greatest cause of mortality worldwide. Additionally, the industry is expanding at an increasingly rapid rate due to rising single-use flexible bronchoscope usage and the strong preference of healthcare professionals for disposable bronchoscopes.
The Disposable Endoscope Market segmentation, based on End User, includes hospitals, diagnostic centers, and others. In 2022, the hospitals category accounted for a larger market share. The primary element driving segment demand is an increase in the number of hospitals providing endoscopic treatments. Additionally, advantages including easy access to hospitals and affordable services are promoting industry expansion. In addition, it is anticipated that government programmes to improve the healthcare system will accelerate segment growth in the years to come.
Figure 1: Disposable Endoscope Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Disposable Endoscope Market dominated this market in 2022 (45.80%). This is due to the presence of a sizable number of market participants and the numerous strategic initiatives they have implemented. As the majority of players initially sought U.S. FDA approval to debut their product in the country, the U.S. is the largest market in North America. Another reason driving the region's rise is the growing awareness of single-use endoscopes' low cost and high per capita health spending. Furthermore, the region of North America has had strong growth as a result of its well-developed healthcare infrastructure, encouraging government initiatives, and optimal treatment coverage. Further, the U.S. market of Disposable Endoscope held the largest market share, and the Canada market of Disposable Endoscope was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: DISPOSABLE ENDOSCOPE MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Disposable Endoscope market accounts for the significant market share. Healthcare workers in Europe are using disposable endoscopes more frequently as a result of growing awareness of their advantages. Further, the German market of Disposable Endoscope held the largest market share, and the U.K market of Disposable Endoscope was the fastest growing market in the European region
The Asia Pacific Disposable Endoscope market, is expected to register fastest growth from 2023 to 2032. This can be linked to the high prevalence of the target diseases, and the growth of the region is expected to gain traction due to the larger population pool. Due to the booming demand for medical equipment in the APAC area, the region's infrastructure for healthcare is developing, and market players are increasing their investments. Additionally, a bigger switch from reusable to disposable endoscopes in the region and an uptick in epidemiological factors hold tremendous promise for the expansion of the region. Moreover, China’s market of Disposable Endoscope held the largest market share, and the Indian market of Disposable Endoscope was the fastest growing market in the Asia-Pacific region.
Disposable Endoscope Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Disposable Endoscope, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Disposable Endoscope industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Disposable Endoscope industry to benefit clients and increase the market sector. In recent years, the Disposable Endoscope industry has offered some of the most significant advantages to medicine. Major players in the market of Disposable Endoscope, including Boston Scientific Corporation, FlexicareMedical Limited, NeoScope, Inc., Otu Medical Inc., Cooper Surgical, Inc., Hill Rom Holdings, hoya corporation, karl storz endoscopy, OLYMPUS, and Ambu AS, are attempting to increase market demand by investing in research and development operations.
ZSquare is a company that creates single-use endoscope technology with the goal of eliminating the chance of cross-contamination as a result of subpar sterilisation. The company's disposable devices minimise the costs, hazards, and delays associated with sterilisation, allowing doctors to access cutting-edge endoscopic diagnostic tools that democratise patient care while enhancing patient outcomes and hospital productivity. ZSquare, a pioneer in the development of high-performance, single-use endoscopes, announced in July 2022 that the FDA has authorised the sale of its first product, the Square ENT-FlexTM Rhinolaryngoscope.
The Asian Institute of Gastroenterology (AIG), established in Hyderabad, India, offers treatment services for gastroenterology-related illnesses. With well-equipped technology and committed staff, the organisation provides patients with outpatient endoscopic surgical procedures, colonoscopies, ERCP (diagnostic and therapeutic), endoscopic ultrasonography, endoscopic stitching, and capsule endoscopies. A partnership between Olympus Corporation and Cybernet Systems Co. Ltd. allowed for the delivery of an AI diagnostic support system in October 2020.
Key Companies in the market of Disposable Endoscope include
FlexicareMedical Limited
NeoScope, Inc.
Otu Medical Inc.
Cooper Surgical, Inc.
Hill Rom Holdings
karl storz endoscopy
OLYMPUS
Ambu AS
Disposable Endoscope Industry Developments
March 2022 Zsquare launched its single-use ENT endoscope after raising USD 15 million in a fundraising round led by private equity company Chartered Group.
In February 2022 In the United States, the 510(k) regulatory clearance was granted for the Ambu aScope Gastro and Ambu aBox 2. The aScope Gastro, Ambu's first sterile single-use gastroscope, combines state-of-the-art display and processing technology with new advanced imaging features.
Bronchoscopy
Urologic Endoscopy
ENT Endoscopy
Arthroscopy
Others
Hospitals
Diagnostic Centers
Others
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)